Herdecke, Germany

Jan Eickhoff

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 27(Granted Patents)


Location History:

  • Heerdecke, DE (2016)
  • Herdecke, DE (2015 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jan Eickhoff

Introduction

Jan Eickhoff is a prominent inventor based in Herdecke, Germany. With a remarkable portfolio of 8 patents, Eickhoff has made significant advancements in the field of pharmaceutical and medicinal chemistry. His work primarily focuses on innovative derivatives that serve as selective inhibitors for various diseases.

Latest Patents

Among his latest patents, Jan Eickhoff has developed derivatives such as pyrazolo-triazine and pyrazolo-pyrimidine. These compounds are recognized for their potential as selective inhibitors of cyclin-dependent kinase (CDK). The inventions encompass pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives, along with their pharmaceutically acceptable salts. The therapeutic applications of these derivatives include the prophylaxis and treatment of cell proliferative diseases, inflammatory diseases, immunological diseases, cardiovascular diseases, and infectious diseases. Furthermore, Eickhoff's patents also cover pharmaceutical compositions containing these innovative compounds.

Career Highlights

Jan Eickhoff has held significant positions in leading pharmaceutical companies. Notably, he has worked at the Lead Discovery Center GmbH and Bayer Intellectual Property GmbH. His role in these organizations has enabled him to contribute effectively to the progression of drug discovery and development, further enhancing his reputation in the field.

Collaborations

Throughout his career, Jan has collaborated with esteemed colleagues such as Uwe Koch and Gunther Zischinsky. These partnerships have allowed for the exchange of innovative ideas and have played a crucial role in the successful development of his patented inventions.

Conclusion

Jan Eickhoff stands out as a visionary inventor whose contributions in medicinal chemistry continue to impact the medical field positively. His groundbreaking work on selective CDK inhibitors exemplifies the importance of innovation in combating various health challenges. With his impressive array of patents, Eickhoff is poised to further influence pharmaceutical advancements in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…